DrugPatentWatch Database Preview

ADDERALL XR 10 Drug Profile

« Back to Dashboard

Which patents cover Adderall Xr 10, and when can generic versions of Adderall Xr 10 launch?

Adderall Xr 10 is a drug marketed by Shire and is included in one NDA. There are four patents protecting this drug.

This drug has ten patent family members in eight countries.

The generic ingredient in ADDERALL XR 10 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.

Summary for ADDERALL XR 10

International Patents:	10
US Patents:	4
Applicants:	1
NDAs:	1
Suppliers / Packagers:	6
Bulk Api Vendors:	1
Clinical Trials:	35
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ADDERALL XR 10
DailyMed Link:	ADDERALL XR 10 at DailyMed

Pharmacology for ADDERALL XR 10

Drug Class	Central Nervous System Stimulant
Physiological Effect	Central Nervous System Stimulation

Synonyms for ADDERALL XR 10

24 HR Amphetamine aspartate

ADDERALL 10

ADDERALL 12.5

ADDERALL 15

ADDERALL 20

ADDERALL 30

ADDERALL 5

ADDERALL 7.5

ADDERALL XR 15

ADDERALL XR 20

ADDERALL XR 25

ADDERALL XR 30

ADDERALL XR 5

Adzenys XR-ODT

Amphetamine aspartate mixture with amphetamine sulfate, dextroamphetamine saccharate and dextroamphetamine sulfate

Dextroamphetamine sulfate mixture with dextroamphetamine saccharate and amphetamine aspartate monohydrate and amphetamine sulfate

S900000010

US Patents and Regulatory Information for ADDERALL XR 10

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shire	ADDERALL XR 10	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-001	Oct 11, 2001	AB	RX	Yes	No
Shire	ADDERALL XR 10	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-001	Oct 11, 2001	AB	RX	Yes	No
Shire	ADDERALL XR 10	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-001	Oct 11, 2001	AB	RX	Yes	No
Shire	ADDERALL XR 10	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-001	Oct 11, 2001	AB	RX	Yes	No

Expired US Patents for ADDERALL XR 10

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Shire	ADDERALL XR 10	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-001	Oct 11, 2001
Shire	ADDERALL XR 10	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-001	Oct 11, 2001
Shire	ADDERALL XR 10	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-001	Oct 11, 2001
Shire	ADDERALL XR 10	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-001	Oct 11, 2001

International Patents for ADDERALL XR 10

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	0023055
Spain	2323910
Germany	69940673
European Patent Office	1977736
Japan	2008303223